Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion.
D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D004206:Disopyramide / Q000009:adverse effects / Q000627:therapeutic use; D004562:Electrocardiography; D004594:Electrophysiology; D005260:Female; D006321:Heart / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011725:Pyridines / Q000627:therapeutic use*; D012008:Recurrence
D000889:Anti-Arrhythmia Agents; D010919:Placebos; D011725:Pyridines; D004206:Disopyramide